Enhancing Anti-Cancer Activity Of Immunomodulatory Fc Fusion Proteins

Patent No. EP2925350 (titled "Enhancing Anti-Cancer Activity Of Immunomodulatory Fc Fusion Proteins") was filed by Bristol Myers Squibb on Dec 3, 2013. The application was issued on Jan 30, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
PLOUGMANN VINGTOFT	Oct 29, 2019	-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Sep 21, 2021
Refund of fees
Sep 17, 2021
F3324 Closure of the appeal proceedings: withdrawal of the appeal/ application/ opposition
Sep 17, 2021
F3324 Closure of the appeal proceedings: withdrawal of the appeal/ application/ opposition
Sep 15, 2021
Termination of the opposition proceedings with maintenance of patent
Sep 8, 2021
(Electronic) Receipt
Sep 8, 2021
Letter accompanying subsequently filed items
Sep 8, 2021
Withdrawal of an appeal
Sep 1, 2021
Composition of the board (T)
Aug 11, 2021
F3204 Communication of the file number to the parties
Aug 11, 2021
F3204 Communication of the file number to the parties
Aug 4, 2021
(Electronic) Receipt
Aug 4, 2021
Letter accompanying subsequently filed items
Aug 4, 2021
Notice of appeal
Jun 8, 2021
Advice of delivery
May 28, 2021
Advice of delivery
May 28, 2021
Annex to the communication - opposition
May 28, 2021
Decision of the Opposition Division and instruction
May 28, 2021
Decision rejecting the opposition
May 28, 2021
Grounds for the decision (Annex) - opposition
May 28, 2021
Internal form - Opposition/addressees
May 28, 2021
Internal form - Opposition/addressees
May 28, 2021
Means of redress
May 28, 2021
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
May 28, 2021
Minutes of the oral proceedings (Opposition Division) - conclusion of the proceedings
May 28, 2021
Minutes of the oral proceedings (Opposition Division) - introduction of the parties
May 28, 2021
Provision of a copy of the minutes - opposition procedure
May 28, 2021
Transmittal of decision / summons - opposition
May 28, 2021
Transmittal of decision / summons - opposition
Apr 20, 2021
Information about the result of oral proceedings
Mar 23, 2021
Brief communication - Opposition proceedings
Mar 17, 2021
(Electronic) Receipt
Mar 17, 2021
Letter accompanying subsequently filed items
Mar 17, 2021
Written submission in preparation to/during oral proceedings
Feb 24, 2021
Brief communication - Opposition proceedings
Feb 24, 2021
Brief communication - Opposition proceedings
Feb 19, 2021
(Electronic) Receipt
Feb 19, 2021
(Electronic) Receipt
Feb 19, 2021
Citation in opposition procedure - 034
Feb 19, 2021
Citation in opposition procedure - 035
Feb 19, 2021
Citation in opposition procedure - 036
Feb 19, 2021
Citation in opposition procedure - 037
Feb 19, 2021
Consolidated list of cited opposition documents
Feb 19, 2021
Letter accompanying subsequently filed items
Feb 19, 2021
Non-public letter accompanying subsequently filed items
Feb 19, 2021
Written submission in preparation to/during oral proceedings
Feb 19, 2021
Written submission in preparation to/during oral proceedings
Jan 20, 2021
Notification concerning the date of oral proceedings
Jan 20, 2021
Notification concerning the date of oral proceedings
Jul 15, 2020
Advice of delivery
Jul 14, 2020
(Electronic) Receipt
Jul 14, 2020
Advice of delivery
Jul 14, 2020
Letter accompanying subsequently filed items
Jul 6, 2020
Acknowledgement of a document
Jul 6, 2020
Acknowledgement of a document
Jul 6, 2020
Annex to the communication - opposition
Jul 6, 2020
Information concerning oral proceedings
Jul 6, 2020
Summons to attend oral proceedings
Jul 6, 2020
Summons to attend oral proceedings
Mar 27, 2020
Brief communication - Opposition proceedings
Mar 23, 2020
(Electronic) Receipt
Mar 23, 2020
Citation in opposition procedure - 033
Mar 23, 2020
Letter accompanying subsequently filed items
Mar 23, 2020
Reply of the patent proprietor to the notice(s) of opposition
Feb 5, 2020
Communication of amended entries concerning the representative
Nov 12, 2019
Communication of a notice of opposition and request to file observations
Nov 12, 2019
Notice of further oppositions to opponent(s)
Nov 4, 2019
Communication of a notice of opposition - first information to patent proprietor
Oct 29, 2019
(Electronic) Receipt
Oct 29, 2019
Citation in opposition procedure - 001
Oct 29, 2019
Citation in opposition procedure - 002
Oct 29, 2019
Citation in opposition procedure - 003
Oct 29, 2019
Citation in opposition procedure - 004
Oct 29, 2019
Citation in opposition procedure - 005
Oct 29, 2019
Citation in opposition procedure - 006
Oct 29, 2019
Citation in opposition procedure - 007
Oct 29, 2019
Citation in opposition procedure - 008
Oct 29, 2019
Citation in opposition procedure - 009
Oct 29, 2019
Citation in opposition procedure - 010
Oct 29, 2019
Citation in opposition procedure - 011
Oct 29, 2019
Citation in opposition procedure - 012
Oct 29, 2019
Citation in opposition procedure - 013
Oct 29, 2019
Citation in opposition procedure - 014
Oct 29, 2019
Citation in opposition procedure - 015
Oct 29, 2019
Citation in opposition procedure - 016
Oct 29, 2019
Citation in opposition procedure - 017
Oct 29, 2019
Citation in opposition procedure - 018
Oct 29, 2019
Citation in opposition procedure - 019
Oct 29, 2019
Citation in opposition procedure - 020
Oct 29, 2019
Citation in opposition procedure - 021
Oct 29, 2019
Citation in opposition procedure - 022
Oct 29, 2019
Citation in opposition procedure - 023
Oct 29, 2019
Citation in opposition procedure - 024
Oct 29, 2019
Citation in opposition procedure - 025
Oct 29, 2019
Citation in opposition procedure - 026
Oct 29, 2019
Citation in opposition procedure - 027
Oct 29, 2019
Citation in opposition procedure - 028
Oct 29, 2019
Citation in opposition procedure - 029
Oct 29, 2019
Citation in opposition procedure - 030
Oct 29, 2019
Citation in opposition procedure - 031
Oct 29, 2019
Citation in opposition procedure - 032
Oct 29, 2019
Notice of opposition
Oct 29, 2019
Notice of opposition
Oct 29, 2019
Patent document cited during the opposition procedure
Oct 29, 2019
Priority document
Oct 29, 2019
Priority document
Oct 29, 2019
Published international application - A1
Feb 11, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jan 7, 2019
Decision to grant a European patent
Nov 21, 2018
(Electronic) Receipt
Nov 21, 2018
Filing of the translations of the claims
Nov 21, 2018
French translation of claims
Nov 21, 2018
German translation of the claims
Nov 21, 2018
Letter accompanying subsequently filed items
Aug 10, 2018
Bibliographic data of the European patent application
Aug 10, 2018
Communication about intention to grant a European patent
Aug 10, 2018
Intention to grant (signatures)
Aug 10, 2018
Text intended for grant (clean copy)
Aug 10, 2018
Text intended for grant (version for approval)
Aug 1, 2018
Annex to a communication
Aug 1, 2018
Annex to a communication
Aug 1, 2018
Annex to the communication
Aug 1, 2018
Minutes of the oral proceedings (examining division)
Aug 1, 2018
Minutes of the oral proceedings (examining division)
Aug 1, 2018
Minutes of the oral proceedings (examining division)
Aug 1, 2018
Provision of a copy of the minutes of oral proceedings
Jul 30, 2018
Annex to the communication
Jul 30, 2018
Consultation by telephone/in person
Jul 30, 2018
Result of consultation by telephone/in person
Apr 25, 2018
(Electronic) Receipt
Apr 25, 2018
Amended claims with annotations
Apr 25, 2018
Amended claims with annotations
Apr 25, 2018
Claims
Apr 25, 2018
Claims
Apr 25, 2018
Letter accompanying subsequently filed items
Apr 25, 2018
Letter dealing with oral proceedings
Nov 15, 2017
Advice of delivery
Nov 10, 2017
Advice of delivery
Nov 8, 2017
Acknowledgement of a document
Nov 8, 2017
Annex to the communication
Nov 8, 2017
Preparation for oral proceedings
Nov 8, 2017
Summons to attend oral proceedings
Jul 20, 2017
(Electronic) Receipt
Jul 20, 2017
Amended claims with annotations
Jul 20, 2017
Claims
Jul 20, 2017
Letter accompanying subsequently filed items
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Non-patent literature cited during the examination procedure
Jul 20, 2017
Reply to communication from the Examining Division
May 11, 2017
Grant of extension of time limit (examination procedure)
May 8, 2017
Request for extension of time limit to communication from the Examining Division
Jan 12, 2017
Annex to the communication
Jan 12, 2017
Communication from the Examining Division
Jul 12, 2016
Annex to the communication
Jul 12, 2016
Communication from the examining division with an Invitation to pay a search fee(s)
Jul 7, 2016
Examination started
Feb 1, 2016
(Electronic) Receipt
Feb 1, 2016
Amended claims filed after receipt of (European) search report
Feb 1, 2016
Amended claims with annotations
Feb 1, 2016
Amendments received before examination
Feb 1, 2016
Letter accompanying subsequently filed items
Sep 9, 2015
Notification on forthcoming publication of bibliographic data
Jul 22, 2015
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
Jul 8, 2015
Communication to designated inventor
Jul 8, 2015
Communication to designated inventor
Jul 8, 2015
Communication to designated inventor
Jul 8, 2015
Communication to designated inventor
Jul 8, 2015
Communication to designated inventor
Jun 24, 2015
(Electronic) Receipt
Jun 24, 2015
Request for entry into the European phase
Jun 23, 2015
Copy of the international preliminary report on patentability
May 27, 2015
Notification of the recording of a change
Apr 17, 2015
Information on entry into European phase
Nov 11, 2014
CDS Clean up - amended applicant details
Sep 12, 2014
Request for correction
Jul 2, 2014
Priority document (electronically transmitted)
Jul 2, 2014
Priority document (electronically transmitted)
Jun 12, 2014
Copy of the international search report
Jun 12, 2014
Published international application - A1
Apr 14, 2014
Written opinion of the ISA, boxes No. I to VIII
Apr 14, 2014
Written opinion of the ISA, cover sheet
Apr 14, 2014
Written opinion of the ISA, supplemental box
Mar 26, 2014
Notification relating to declaration under Rule 4.17 PCT (copy for ISA/EP)
Mar 20, 2014
Annex
Dec 13, 2013
Abstract
Dec 13, 2013
Claims
Dec 13, 2013
Description
Dec 13, 2013
Drawings

EP2925350

BRISTOL MYERS SQUIBB

Application Number: EP13811698A
Filing Date: Dec 3, 2013
Status: Opposition Rejected; Sep 17, 2021
Publication Date: Jan 30, 2019
External Links: Slate, Register , Google Patents

IP Verse

Enhancing Anti-Cancer Activity Of Immunomodulatory Fc Fusion Proteins

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2925350